REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $557,000 | +139.1% | 20,619 | +146.8% | 0.01% | +133.3% |
Q3 2021 | $233,000 | -15.0% | 8,355 | -9.5% | 0.01% | -33.3% |
Q2 2021 | $274,000 | -30.6% | 9,228 | -41.3% | 0.01% | -62.5% |
Q3 2020 | $395,000 | -15.6% | 15,718 | -18.1% | 0.02% | -25.0% |
Q2 2020 | $468,000 | +32.2% | 19,180 | -19.7% | 0.03% | +10.3% |
Q1 2020 | $354,000 | -49.5% | 23,900 | -44.7% | 0.03% | -52.5% |
Q4 2019 | $701,000 | +109.3% | 43,200 | +297.1% | 0.06% | +52.5% |
Q1 2018 | $335,000 | – | 10,878 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |